Pfizer
PFIZER
Quick Bite
Price To Earnings Ratio 37.82 | Sector PE 65.61 |
PB Ratio 7.36 | Sector PB 8.94 |
EPS 136.38 | Dividend Yield 2.02 |
Today's Volume 8.908 K | 5 Day Avg. Volume 13.963 K |
PEG Ratio 20.33 | Market Cap. ₹ 23,820.00 Cr. |
Returns Comparison
| Time | PFIZER | VS | Industry |
|---|---|---|---|
| 1 Day | 2.38% | 1.42% | |
| 1 Week | 1.44% | 1.36% | |
| 1 Month | -3.83% | -0.56% | |
| 6 Months | 15.35% | 14.7% | |
| 1 Year | 15.35% | 46.06% |
Technical Trend
Pivot Levels
Moving Averages
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 5153.61 | Bullish |
| 20 | 5143.22 | Bullish |
| 30 | 5288.5 | Bearish |
| 50 | 5419.47 | Bearish |
| 100 | 5504.88 | Bearish |
| 200 | 4982.19 | Bullish |
Shareholding Updates
Cash Flow
| Annual | FY 2008 | FY 2007 | FY 2006 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 237.76 | 16.63 | 123.19 | ||||
| Investing Activities | -78.87 | 232.35 | -47.99 | ||||
| Financing Activities | -95.20 | -75.90 | -33.82 | ||||
| Net Cash Flow | 63.69 | 173.09 | 41.38 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Income Statement
Balance Sheet
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Pfizer | 2.38 | 1.44 | -3.83 | 15.35 | 15.35 |
| Alembic | 1.92 | -1.81 | 3.67 | -6.7 | -6.7 |
| Aurobindo Pharma | 0.55 | -1.52 | -14.58 | -10 | 19.75 |
| Fortis Healthcare | 0.83 | 11.39 | 15.86 | 32.89 | 84.42 |
| Ajanta Pharmaceuticals | 1.18 | 5.73 | 2.08 | 13.83 | 47.7 |
About Pfizer
Pfizer Share Price
Pfizer Limited is an Indian pharmaceutical company. The company's field of activity is the production, distribution, trade and export of medicines. The company has its own manufacturing facility in Goa. The company has several independent contract/third party manufacturers in India. Its product portfolio includes vaccines, anti-infective, cardiac, pain, maternal nutrition, gastrointestinal, anti-pregnancy, anti-inflammatory, anti-nutritional and anti-immune vaccines, and respiratory vaccines. The company's vaccine business focuses on Prevenar 13, a pneumococcal conjugate vaccine administered to infants six weeks of age and older as part of the primary immunisation program, infants, adolescents, adults and the elderly. Its inflammation and immunology portfolio includes two advanced therapies serving patients suffering from chronic immune-related diseases such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.
Pfizer FAQs
How to Buy Pfizer Share?
What's Pfizer share price today?
What is the Market Cap of Pfizer?
What is the PE and PB ratio of Pfizer?
What is the 52 Week High and Low of Pfizer Share?